NCT00302562

Brief Summary

Investigate the role of MMPs in the CXCL12-induced invasion of laryngeal and hypopharyngeal squamous cell carcinoma

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Aug 2006

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 12, 2006

Completed
2 days until next milestone

First Posted

Study publicly available on registry

March 14, 2006

Completed
5 months until next milestone

Study Start

First participant enrolled

August 1, 2006

Completed
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2007

Completed
Last Updated

March 14, 2006

Status Verified

December 1, 2005

First QC Date

March 12, 2006

Last Update Submit

March 12, 2006

Conditions

Laryngeal CancerHypopharyngeal Cancer

Keywords

laryngeal cancerhypopharyngeal cancerCXCR4CXCL12matrix metalloproteinases(MMPs)metastasis

Eligibility Criteria

Age30 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • laryngeal and hypopharyngeal squamous cell carcinoma

You may not qualify if:

  • other pathological type

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Taiwan University Hospital

Taipei, 100, Taiwan

Location

MeSH Terms

Conditions

Laryngeal NeoplasmsHypopharyngeal NeoplasmsNeoplasm Metastasis

Condition Hierarchy (Ancestors)

Otorhinolaryngologic NeoplasmsHead and Neck NeoplasmsNeoplasms by SiteNeoplasmsLaryngeal DiseasesRespiratory Tract DiseasesRespiratory Tract NeoplasmsOtorhinolaryngologic DiseasesPharyngeal NeoplasmsPharyngeal DiseasesStomatognathic DiseasesNeoplastic ProcessesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Ching-Ting Tan, MD,PhD

    National Taiwan University Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Ching-Ting Tan, MD, PhD

CONTACT

886-2-23123456christin@ha.mc.ntu.edu.tw

Study Design

Study Type
observational
Observational Model
NATURAL HISTORY
Time Perspective
OTHER
Sponsor Type
OTHER

Study Record Dates

First Submitted

March 12, 2006

First Posted

March 14, 2006

Study Start

August 1, 2006

Study Completion

July 1, 2007

Last Updated

March 14, 2006

Record last verified: 2005-12

Locations

TW(1)